Why Writing DNA Is Harder Than Reading It

Over the past two decades, the cost of reading DNA has fallen faster than almost any technology in history. Sequencing a human genome now costs a few hundred dollars. Editing specific genes has become so precise that researchers can change single letters in the genetic code. Yet synthesizing long DNA sequences—writing new genetic instructions from scratch—remains expensive, slow, and prone to mistakes.

This gap matters because it shapes what synthetic biology can actually do. To understand why writing is harder than reading or editing, it helps to see them as three separate challenges.

Reading: Finding the Signal

DNA sequencing works by breaking DNA into small fragments, reading each one, and reassembling them computationally. Modern sequencers can process millions of fragments in parallel. The chemistry is well-established. The bottleneck is not the biology but the data: managing, storing, and analyzing the output.

This is why sequencing became cheap so quickly. Once the underlying method works, scaling it up is mainly an engineering problem. Manufacturers built bigger machines, ran more samples at once, and improved the reagents. The cost per base pair dropped exponentially.

Editing: Changing One Thing

Gene editing tools like CRISPR work by finding a specific location in the genome and making a precise cut. The cell's own repair machinery then fixes the break, often incorporating a desired change. The tool is targeted: you specify the exact spot you want to alter, and the system goes there.

This precision is powerful but also limited. You can change a few bases, delete a section, or insert a short sequence. The system works because it exploits the cell's existing ability to repair DNA damage. You are not building anything from scratch; you are modifying what is already there.

Writing: Building from Nothing

Synthesizing DNA is different. You start with no DNA and must build a long sequence, base by base, in the correct order. There is no template to copy from and no existing structure to modify. You must construct it.

The standard method uses chemistry to add one base at a time to a growing chain. This is slow. Adding each base takes time, and the reaction is not perfectly efficient—sometimes a base fails to attach, or an unwanted base gets added instead. These errors accumulate. A synthesis error rate of even 99.9% per base means that in a sequence of 10,000 bases, you expect roughly 10 mistakes.

For short sequences—a few hundred bases—this is manageable. For long sequences, errors become a serious problem. Checking and correcting them requires additional steps, which add cost and time.

Why the Bottleneck Matters

The practical limit for current DNA synthesis is roughly 10,000 to 50,000 bases of reliable sequence. Anything longer requires breaking the job into smaller pieces, synthesizing each one, and then assembling them together. Assembly introduces its own errors and complexity.

This creates a real constraint for synthetic biology. A bacterial genome is typically several million bases. A mammalian genome is billions. Even modest synthetic projects—a redesigned metabolic pathway, a new regulatory circuit—often need sequences longer than what can be synthesized reliably in one piece.

Researchers have developed workarounds. They use computational methods to design sequences that are easier to synthesize. They break large projects into smaller, overlapping fragments and use molecular assembly techniques to join them. They screen the final product to catch errors. None of these solutions is as straightforward as reading or editing.

Where the Field Is Heading

Several groups are working to improve synthesis. Some are exploring new chemistry that might add bases faster or more accurately. Others are developing better error-correction methods. A few are investigating biological approaches—using cells or enzymes to build DNA, rather than pure chemistry.

Progress has been real but incremental. Synthesis costs have fallen, but not as dramatically as sequencing. The fundamental challenge remains: building a long, accurate sequence from scratch is harder than reading an existing one or making a small change to it.

This is not a permanent barrier. As synthesis improves, it will enable new kinds of work: larger synthetic genomes, more complex engineered systems, faster iteration on designs. But for now, it is the limiting step in many projects.

Understanding what is easy and what is hard in molecular biology shapes what questions researchers can actually answer. Careful analysis of synthesis capabilities and limitations is essential for realistic project planning.